4621 - 4630 of 9035 Results
Title
Year
-
OPENTitle: Drug repurposing to target proteostasis and prevent neurodegeneration: accelerating translational effortsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 140Issue #: 6Start Page: 1544End Page: 1547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awx107Best OA location URL: https://academic.oup.com/brain/article-pdf/140/6/1544/18186427/awx107.pdfCitation Count: 20
-
OPENTitle: Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJournal Name: eBioMedicinePublisher: Elsevier BVVol: 119Issue #:Start Page: 105866End Page: 105866Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105866Best OA location URL: https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(25)00310-X.pdfCitation Count: 3
- From correlational approaches to meta-analytical symptom reading in individual patients: Bilateral lesions in the inferior frontal junction specifically cause dysexecutive syndrome2020RESTRICTEDTitle: From correlational approaches to meta-analytical symptom reading in individual patients: Bilateral lesions in the inferior frontal junction specifically cause dysexecutive syndromeJournal Name: CortexPublisher: Elsevier BVVol: 128Issue #:Start Page: 73End Page: 87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cortex.2020.03.010Citation Count: 14
-
OPENTitle: Revealing and Exploiting the Biochemistry of O -GlcNAc through Protein SemisynthesisJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 7Start Page: 801End Page: 811Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.6c00095Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13035441/Citation Count: 0
-
OPENTitle: Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 4Start Page: 2364End Page: 2364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25042364Best OA location URL: https://www.mdpi.com/1422-0067/25/4/2364/pdf?version=1708157539Citation Count: 14
- Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's disease2008RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0
-
OPENTitle: Evaluation of alpha-synuclein immunohistochemical methods for the detection of Lewy-type synucleinopathy in gastrointestinal biopsiesJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 35End Page: 35Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-016-0305-8Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-016-0305-8Citation Count: 71
-
OPENTitle: NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stressJournal Name: The FASEB JournalPublisher: WileyVol: 33Issue #: 10Start Page: 11223End Page: 11234Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1096/fj.201900830rBest OA location URL: https://doi.org/10.1096/fj.201900830rCitation Count: 129
-
OPENTitle: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 524End Page: 524Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00524Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00524/pdfCitation Count: 48
-
OPENTitle: Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 139Issue #: 12Start Page: 3217End Page: 3236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/aww238Best OA location URL: https://academic.oup.com/brain/article-pdf/139/12/3217/24173157/aww238.pdfCitation Count: 156